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Abstract
Objectives. To document the practice and training opportunities of US-guided arthrocentesis and joint
injection (UGAJ) among rheumatologists in the member countries of the European League Against
Rheumatism (EULAR).
Methods. An English-language questionnaire, containing questions on demographics, clinical and prac-
tical aspects of UGAJ, training options in UGAJ for rheumatologists, UGAJ education in the rheumatology
training curriculum and other structured education programmes in UGAJ was sent to three different
groups: (i) all national rheumatology societies of EULAR; (ii) all national societies of the European
Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB); and (iii) 22 senior rheumatolo-
gists involved in EULAR musculoskeletal US training from 14 European countries, who were also asked to
circulate the questionnaire among relevant colleagues.
Results. Thirty-three (75%) of 44 countries responded to the questionnaire (61.3% of national rheuma-
tology societies, 25% of the national US societies and 100% of expert ultrasonographers). In the majority
of countries (85%) <10% of rheumatologists routinely perform UGAJ in clinical practice, while the remain-
ing countries (15%) reported a rate of 1050%. The percentage of rheumatologists receiving training in
UGAJ was <10% in the majority (72.7%) of countries.
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Conclusion. The study highlights the relatively low prevalence of UGAJ as compared with the high
(>80%) rate of rheumatologists performing conventional joint injection in most of the surveyed countries.
The reported variations in practice and the lack of available structured training programmes for trainees in
most countries indicates the need for standardization in areas including training guidelines.
Key words: musculoskeletal ultrasound, ultrasound-guided arthrocentesis, ultrasound-guided joint injection,
education, training, Europe
Introduction
In addition to its primary use as a diagnostic tool, muscu-
loskeletal ultrasonography (MSUS) is increasingly valued
by rheumatologists for its use in guiding musculoskeletal
interventions, which offer the chance to improve efficacy
by enabling visualization of the target area. Among mus-
culoskeletal interventions, arthrocentesis and joint injec-
tion as well as soft-tissue injections using various
compounds are the procedures perhaps most character-
istic to the profession of clinical rheumatology. Among
various imaging-guided interventions, US guidance has
emerged as one the most widely utilized modalities. US
can be used to detect synovial effusion, the target of
arthrocentesis, or to detect other musculoskeletal path-
ology (enthesitis, tenosynovitis, etc.) not necessarily asso-
ciated with the presence of synovial effusion for which an
injection may be indicated. Generally, all US-guided inter-
ventions are performed by using one of the two methods:
indirect and direct visualization. Indirect visualization in-
volves the performance of a pre-intervention US examin-
ation. The information gained during this examination is
then used in the planning of the intervention (type of
needle, route, angle, etc.), which is then performed simi-
larly to conventional, i.e. non-imaging guided, arthrocent-
esis or joint injection (CAJ). The direct visualization
method involves the performance of an US examination
simultaneously with the intervention, which allows
real-time visualization of the target lesion along with the
inserted instrument, i.e. the intervention itself. Direct visu-
alization involves the physical presence of the US trans-
ducer in the area of the intervention. Real-time scanning
diminishes the rate of complications [1], which are infre-
quent when the operator maintains strict sterility. The first
report of US guidance in aspiration was reported by
Kratochwill [2] to sample amniotic fluid, while Gombels
and Darlington [3] and Komppa et al. [4] reported the
first US-guided aspiration of SF from the shoulder and
hip, respectively. A detailed description of US-guided
interventional musculoskeletal procedures may be found
in reviews and textbooks [5, 6]. A number of studies have
addressed the success rate of US-guided vs conventional
arthrocentesis as well as the accuracy of US-guided vs
conventional joint injection, while only a relatively small
number of studies have addressed outcome [714]. Very
little is known, however, regarding practice and training in
US-guided arthrocentesis and joint injection (UGAJ). Due
to the scarcity of information, the aim of this survey was to
document the practice of UGAJ and training opportunities
among rheumatologists in the member countries of the
European League Against Rheumatism (EULAR).
Methods
Study design
An English-language questionnaire was designed by a
group of senior ultrasonographer rheumatologists. The
questionnaire was sent by e-mail or regular mail to three
different groups in late 2009 to early 2010:
(i) all 44 national rheumatology societies of EULAR
(incorporating 41 European countries, Armenia,
Israel and Lebanon);
(ii) all 29 national societies of the European Federation
of Societies for Ultrasound in Medicine and Biology
(EFSUMB) (28 European countries and Israel; all
included among the 44 EULAR countries); and
(iii) 22 rheumatologists expert in UGAJ from 14
European countries who have been involved in
both national and international training programmes
in MSUS. These ultrasonographer rheumatologists
were from the following countries: Denmark,
Finland, France, Germany, Hungary, Ireland, Italy,
The Netherlands, Norway, Poland, Serbia, Spain,
Switzerland and the UK. The questionnaire was
accompanied by an explanation regarding the pur-
pose of the survey. Non-responding persons and
organizations were sent a reminder after 8 and
12 weeks.
Questionnaire design
The questions contained in the questionnaire were divided
into three sections: demographics, practice of UGAJ and
training, and education in UGAJ for rheumatologists.
Questions on demographics requested information con-
cerning the country of the responder. Questions on clinical
use and on training and education in UGAJ for rheuma-
tologists requested information concerning the country of
the responder as well as the responder as an individual.
Overall the survey contained 32 questions, including
3 subquestions, many of which had multiple response
options.
Analysis
Simple descriptive and summary statistics were calcu-
lated from the responses. When contradictory answers
were received regarding information concerning countries
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between the questionnaires of UGAJ experts and the na-
tional rheumatology societies, respondents were asked to
review the differences and to provide a consensual
response.
Results
Survey
A total of 33 of 44 (75%) countries (Austria, Belgium,
Bulgaria, Croatia, Cyprus, Czech Republic, Denmark,
Estonia, Finland, France, Germany, Hungary, Ireland, Israel,
Italy, Latvia, Lebanon, Lithuania, Malta, Montenegro, The
Netherlands, Norway, Poland, Portugal, Romania, Serbia,
Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey
and UK) responded to our survey. The response rate
was 27 out of 44 (61.3%) with respect to national rheuma-
tology societies; 7 out of 28 (25%) with respect to national
societies of the EFSUMB; and 22 out of 22 (100%) for
rheumatologists expert in UGAJ. Surveys from 48 individ-
uals were collected: among the responders, 22 were
rheumatologists expert in UGAJ, 27 were individuals dele-
gated by respective national rheumatology societies and 7
were individuals delegated by respective national socie-
ties of the EFSUMB. Four responders were delegated
by both their individual societies and four additional re-
sponders were rheumatologist experts who were also
delegates of one of their national societies. Forty-five
out of 48 responders were certified rheumatologists, 2
were trained in internal medicine and 1 was a physical
medicine and rehabilitation specialist. There were minor
contradictory responses concerning questions between
expert rheumatologists and the national rheumatology
societies from five countries, which were resolved by
feedback, and a consensual response was reached in all
cases.
Demographics
The reported number of rheumatologists in European
countries of EULAR ranged from 11 (Cyprus) to 2300
(France). The number of rheumatologists was >500 in
6 out of 33 (18.2%) countries (France, Germany,
Hungary, Italy, Poland and Spain). Fifteen out of
33 (45.4%) countries (Austria, Belgium, Czech Republic,
Denmark, Greece, Israel, The Netherlands, Norway,
Portugal, Romania, Serbia, Sweden, Switzerland,
Turkey and UK) had 100500 rheumatologists. Twelve
of 33 (36.4%) countries (Bulgaria, Croatia, Cyprus,
Estonia, Finland, Ireland, Latvia, Lebanon, Lithuania,
Malta, Montenegro and Slovakia) reported <100
rheumatologists.
Practice of UGAJ among countries
The percentage of rheumatologists performing CAJ was
>80% in 19 of 33 (57.6%) countries, with an additional 8
(24.2%) and 6 (18.2%) countries reporting percentages of
5080% and <50%, respectively. No country reported
<50% for the percentage of rheumatologists performing
CAJ (Fig. 1).
Regarding the percentage of rheumatologists perform-
ing MSUS, 19 out of 33 (57.7%) countries reported <10%,
while 11 (33.3%) reported 1050%. Two out of 33 coun-
tries (6%) (Spain and Norway) reported 5080% and
1 out of 33 countries (3%) (Germany) reported >80%
for the percentage of rheumatologists performing MSUS
(Fig. 1).
Concerning the percentage of rheumatologists perform-
ing UGAJ, 28 out of 33 (84.9%) countries reported <10%,
with the remaining 5 out of 33 (15.1%) countries (Finland,
The Netherlands, Norway, Serbia and Spain) reporting
1050%. In no country was the percentage of rheumatolo-
gists performing UGAJ >50% (Fig. 1).
Rheumatology was listed among medical specialities
that perform UGAJ in 29 out of 33 (87.9%) countries.
Radiologists, sports medicine specialists and orthopaedic
surgeons were reported as specialists performing
UGAJ by 18, 17 and 14 out of 33 countries, respectively
(54, 51 and 42%, respectively). Physical medicine special-
ists, emergency medicine specialists, internists, paediatric
surgeons and general practitioners were also listed as
specialists performing UGAJ by a smaller number of
countries. Latvia, Montenegro, Slovakia and Sweden
were countries where rheumatologists were not reported
as a specialty that routinely performs UGAJ.
Rheumatologists receive reimbursement for UGAJ in
18 out of 33 (54.5%) countries (Croatia, Cyprus, Denmark,
Estonia, Finland, France, Germany, Italy, Lithuania,
Norway, Portugal, Serbia, Romania, Slovakia, Slovenia,
Spain, Switzerland and the UK). Reimbursement is
received in private practice in most [14 out of 33
(42.5%)] countries, in public practice in 2 out of 33 (6%)
(Estonia and Norway), and in both private and public prac-
tice in an additional 2 out of 33 (6%) countries (Germany
and Switzerland).
FIG. 1 Percentage of rheumatologists routinely perform-
ing conventional joint injection and arthrocentesis (CAJ),
musculoskeletal ultrasound (MSUS) or ultrasound-guided
arthrocentesis and joint injection (UGAJ) by percentage of
responding countries (n= 33).
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Practice of UGAJ among individual responders
In addition to data on the practice of UGAJ regarding the
various countries, the survey also collected data concern-
ing the individual practice of UGAJ among the respond-
ers. Forty-three out of 48 (89.5%) responders have
reported performing UGAJ regularly. Out of these 43 re-
sponders, 29 (67.4%) have performed >300, 9 (20.9%)
have performed between 50 and 300, and 5 (11.7%)
have performed <50 UGAJ interventions.
The shoulder joint was the joint most commonly tar-
geted for UGAJ, indicated by 43 out of 43 (100%) re-
sponders who reported performing UGAJ regularly. The
results pertaining to the other joints are shown in Fig. 2.
Thirty-four out of 43 (79%) responders also perform
US-guided entheseal injections, 8 out of 43 (18.6%) per-
form US-guided nerve blocks, 6 out of 43 (13.9%) perform
additional soft-tissue injections (bursa, tendon sheath)
and 5 of 43 (11.6%) perform US-guided barbotage
(repeated injection and aspiration of fluid used commonly
for removing calcification from tendons, i.e. calcifying
tendinitis).
Regarding the compound injected during UGAJ, 42 out
of 43 (97.6%) reported using corticosteroids, 26 out of 43
(60.4%) reported using anaesthetics and 18 out of 43
(41.8%) reported using hyaluronan. Radionuclides and
osmic acid were used by 3 out of 43 (6.9%) and 2 out
of 43 (4.6%) responders, respectively, while saline was
used by 2 out of 43 (4.6%) responders.
UGAJ interventions are generally performed by using
one of the two methods: indirect and direct US guidance.
Twenty-six of the 43 (60.4%) responders who perform
UGAJ regularly report using both indirect and direct US
guidance for their arthrocentesis and joint injection. Ten of
43 (23.3%) perform these interventions only under direct
guidance, while 7 out of 43 (16.3%) utilize only indirect US
guidance.
Of the 36 responders performing interventions under
direct guidance (either exclusively or in addition to indirect
guidance), 32 (89%) perform the entire procedure (US
scan and injection) by themselves without assistance.
Two of 36 (5.5 %) are assisted by rheumatologist col-
leagues and 2 out of 36 (5.5%) are assisted by sonogra-
phers who perform the scanning while they perform the
injection.
The direct visualization method involves the physical
presence of the US transducer in the area of the interven-
tion during the intervention, requiring disinfection and iso-
lation of the transducer. Regarding commonly used items
during the direct procedure, out of the 36 responders per-
forming direct UGAJ (either exclusively or in addition to
indirect guidance), 32 (89%) use an antiseptic during the
procedure. Eighteen out of 36 (50%) use either a sterile
condom or a sterile cover to isolate the transducer and 16
of 36 (44.4%) use sterile gel. Thirteen of the 36 (36.1%)
responders use neither sterile gels nor sterile condoms or
covers to isolate the transducer, relying on antiseptic or, in
one case, sterile gloves only. Seventeen of 36 (47.2%) use
sterile gloves, 10 out of 36 (27.7%) use sterile masks, 7
out of 36 (19.4%) use either sterile aprons or gowns, 5 out
of 36 (13.9%) use sterile drapes, 2 out of 36 (5.5%) use
sterile sponges, 2 out of 36 (5.5%) use sterile caps and 1
out of 36 (2.7%) uses sterile glasses during direct UGAJ.
In order to get a better understanding of the technical
and hygienic protocol followed during direct UGAJ, we
requested information on the actual technique of asepsis
used. Twelve out of 36 (33.3%) responders use the most
sophisticated available method, involving the use of an
antiseptic followed by the application of a sterile
condom/cover over the transducer and sterile gel be-
tween the isolated transducer and the skin surface.
Eleven out of 36 (30.5%) reported using antiseptic alone,
5 out of 36 (13.9%) use a combination of sterile gel and
FIG. 2 Commonly targeted joints for UGAJ by percentage of responders. Each represented joint also includes UGAJ
performed on related bursae, ligaments and tendons. TM, temporomandibular joint; SI, sacroiliac joint; facet, zygapo-
physial joint.
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antiseptic without using a cover/condom and an addition-
al 5 of 36 (13.9%) use a combination of a sterile condom/
cover and antiseptic without using sterile gel. Three out of
36 (8.3%) responders performing direct UGAJ reported
not isolating or disinfecting their transducer during the
procedure (Fig. 3). Concerning the type of US transducer
(linear or curved) used during UGAJ (both indirect and
direct guided), 26 out of 36 (72.2%) reported using linear
transducers, while 10 out of 26 (27.8%) reported using
both curved and linear transducers.
Training in UGAJ for rheumatologists among
countries
The percentage of rheumatologists receiving training in
UGAJ was <10% in 24 out of 33 (72.7%) countries. In
8 out of 33 (24.3%) countries (Bulgaria, France, Israel,
The Netherlands, Norway, Serbia, Slovenia and
Sweden), between 10 and 50% of rheumatologists have
received training in UGAJ, and in 1 out of 33 (3%; Spain)
countries, between 50 and 80% of rheumatologists are
reported to receive training in UGAJ (Fig. 4). In the over-
whelming majority of countries [29 out of 33 (87.8%)],
rheumatologists have been trained in UGAJ through
courses, while informal training from rheumatologists or
other specialists was listed as a means of training by
21 out of 30 (63.6%) countries.
Training in UGAJ is not included in the rheumatology
curriculum in 22 out of 33 (66.7%) countries. Eight out of
33 (24.2%) countries reported that training in UGAJ is an
optional element in their rheumatology curriculum.
Training in UGAJ is obligatory for rheumatology trainees
in only 3 out of 33 (9.1%) countries (Israel, Norway and
Slovenia). However, even where UGAJ is an optional or
obligatory part of the rheumatology curriculum, compe-
tency was only assessed in 5 out of 11 (45.5%) countries
(Latvia, Lithuania, The Netherlands, Norway and Slovenia)
by theoretical/practical examination, with Slovenia add-
itionally requiring the performance of 50 supervised
UGAJ procedures.
Structured training programmes in UGAJ are offered in
11 out of 33 (33.3%) countries (Bulgaria, France,
Germany, Ireland, Israel, The Netherlands, Poland,
Romania, Serbia, Spain and Switzerland); in 8 of these
11 (72.7%) countries (Bulgaria, Germany, Ireland, Israel,
The Netherlands, Poland, Serbia and Spain) the courses
are offered by the national rheumatology society.
Summarizing the responses to the above two questions,
18 out of 33 (54.5%) responding countries have no avail-
able training programmes in UGAJ, neither as structured
FIG. 3 Disinfection/isolation of the transducer during direct UGAJ by percentage of responders.
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training programmes nor as part of the rheumatology
curriculum.
Training in UGAJ among individual responders
Thirty out of 43 responders who regularly perform UGAJ
(69.8%) have been trained in UGAJ, while 13 (30.2%) have
not received training. Of the 30 responders trained in
UGAJ, 25 (83.3%) have participated in UGAJ courses;
9 out of 30 (30%) and 3 out of 30 (10%) also received
training from a rheumatologist or a radiologist experi-
enced in UGAJ, respectively. Three out of 30 (10%)
were trained only by a radiologist and 1 responder
(2.7%) was trained by a physical medicine and rehabilita-
tion specialist.
Discussion
Our present survey is the first to specifically focus on
US-guided musculoskeletal interventions in European
countries. The first report on the practice of UGAJ
among rheumatologists comes from a general survey on
the practice of US among rheumatologists attending the
1999 EULAR Annual Congress. In this survey, 30% of the
92 responders found US useful for guided aspirations/in-
jections, and 12% of the US examinations were per-
formed for UGAJ [15], especially for injecting deep joints
(hip and shoulder), but interestingly, also for the knee. A
later survey conducted in the UK on MSUS practice and
training confirmed these findings, as indicated both by
rheumatologists performing MSUS and rheumatologists
referring for MSUS examination [16]. Recently, an exten-
sive questionnaire investigated the current state of MSUS
training and the extent of implementation among rheuma-
tologists in member countries of EULAR and demon-
strated a huge growth in uptake when compared with
previous surveys, especially in the number of countries
that actually perform MSUS [17]. While earlier surveys
aimed to cover several areas of MSUS, our survey
focused entirely on the use of MSUS for guiding injection,
permitting a complete overview of this indication across
Europe (33 out of 44 EULAR countries). By including ques-
tions concerning both national societies and individual re-
sponders, this survey allowed us to achieve a dual goal in
collecting information on both practice and training in
UGAJ. Despite our intentions to be as comprehensive as
possible, and despite a very good overall response, we
did not receive all the intended information.
Certain limitations, however, could not be avoided,
mostly affecting information pertaining to countries: des-
pite good overall response, a number of countries have
not provided information, and in many countries we
received information from only a single representative,
which introduces bias to the results. Additionally, the
high degree of interest among responders could have
led to overestimated or skewed UGAJ practice character-
istics within the countries.
The remarkable growth in the number of rheumatolo-
gists performing MSUS in the last decade is well docu-
mented by a recent survey [17]. Lacking comparable data,
we can only presume that the same phenomenon has
likely led to a concomitant increase in the number of
rheumatologists performing UGAJ, although the percent-
age of rheumatologists performing UGAJ in European
counties is lower than the percentage of rheumatologists
performing MSUS overall, which means that presumably
most of them continue to perform CAJ.
Similarly, the percentage of rheumatologists receiving
training in UGAJ is also quite low, and the higher preva-
lence of training within the individual responders is likely
due to the high degree of interest and selection bias of the
responders. Currently training in UGAJ is included in the
rheumatology curriculum in only a small number of coun-
tries, and overall structured training programmes are lack-
ing in more than half of the responding countries. Lack of
training and an almost total lack of competency assess-
ment in countries where training is available may explain
the far-ranging differences in the practical aspects of
UGAJ as revealed by the survey.
We could not find any clear guidelines concerning the
general performance of UGAJ or the mode of sterilization/
disinfection used in direct visualization UGAJ. In accord-
ance with the lack of guidelines, our survey has revealed
wide variation with regard to the disinfection and isolation
of the US transducer during direct UGAJ.
In conclusion, despite widespread use and interest in
performing UGAJ, several steps should be performed for
unifying the practice of UGAJ in Europe. A general scar-
city of training programmes and an almost complete lack
of competency assessment is the main observation at
country level, as well as large individual variation among
rheumatologists expert in UGAJ regarding both indication
and technique. The results of our survey highlight the need
for standardization with respect to both practical and
training guidelines.
Rheumatology key message
. Standardized practical and training guidelines are
needed for US-guided arthrocentesis and joint
injection.
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